PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
BLUE bluebird bio
- 7.270
- +0.020+0.28%
Close Feb 14 16:00 ET
- 7.030
- -0.240-3.30%
Post 20:01 ET
70.68MMarket Cap-0.20P/E (TTM)
7.540High7.020Low183.83KVolume7.300Open7.250Pre Close1.34MTurnover1.90%Turnover RatioLossP/E (Static)9.72MShares38.40052wk High-12.12P/B70.22MFloat Cap5.80052wk Low--Dividend TTM9.66MShs Float3057.654Historical High--Div YieldTTM7.17%Amplitude5.800Historical Low7.315Avg Price1Lot Size
About bluebird bio Company
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Company Profile
SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees375
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300
Websitehttp://www.bluebirdbio.com
Company Executives
- Name
- Position
- Salary
- Andrew Obenshain
- Director, President and Chief Executive Officer
- 3.05M
- Thomas J. Klima
- Chief Commercial and Operating Officer
- 1.33M
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- Richard A. Colvin
- Chief Medical Officer
- 1.34M
- Joseph Vittiglio
- Chief Legal and Business Officer
- --
- Mark Vachon
- Chairman of the Board
- 200.91K
- Michael Cloonan
- Director
- --
- Nick Leschly
- Director
- 96.41K
- Najoh Tita-Reid
- Independent Director
- 153.91K
- Dr. Charlotte Jones-Burton, M.D.,M.S.
- Independent Director
- 146.41K
- Richard Paulson, M.B.A.
- Independent Director
- 65.24K
- Dr. John O. Agwunobi, M.D.
- Independent Director
- 160.91K
- Dr. Elisabeth Leiderman, M.D.
- Independent Director
- 167.91K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025